BMN 333
333-301
Phase 3 small_molecule active
Quick answer
BMN 333 for Achondroplasia is a Phase 3 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Achondroplasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active